SAGE THERAPEUTICS INC's ticker is SAGE and the CUSIP is 78667J108. A total of 253 filers reported holding SAGE THERAPEUTICS INC in Q1 2018. The put-call ratio across all filers is 0.89 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2019 | $539,000 | -23.3% | 3,842 | 0.0% | 0.02% | -22.7% |
| Q2 2019 | $703,000 | +20.4% | 3,842 | +4.6% | 0.02% | +15.8% |
| Q1 2019 | $584,000 | +90.8% | 3,672 | +14.9% | 0.02% | +58.3% |
| Q4 2018 | $306,000 | -36.2% | 3,196 | -6.0% | 0.01% | -20.0% |
| Q3 2018 | $480,000 | +352.8% | 3,400 | +400.0% | 0.02% | +400.0% |
| Q2 2018 | $106,000 | +2020.0% | 680 | +1900.0% | 0.00% | – |
| Q1 2018 | $5,000 | – | 34 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GREAT POINT PARTNERS LLC | 1,966,688 | $120,204,000 | 10.81% |
| Integral Health Asset Management, LLC | 230,000 | $14,058,000 | 4.30% |
| Asymmetry Capital Management, L.P. | 102,462 | $6,262,000 | 4.02% |
| ACUTA CAPITAL PARTNERS, LLC | 225,000 | $13,752,000 | 3.74% |
| DAFNA Capital Management LLC | 158,306 | $9,676,000 | 3.14% |
| Bain Capital Life Sciences Investors, LLC | 499,100 | $30,505,000 | 2.84% |
| Boxer Capital, LLC | 1,094,000 | $66,865,000 | 2.31% |
| Palo Alto Investors LP | 590,200 | $36,073,000 | 1.98% |
| Logos Global Management LP | 250,000 | $15,280,000 | 1.96% |
| Bellevue Group AG | 1,579,504 | $96,539,000 | 1.33% |